Management of immune checkpoint inhibitor‐related adverse events: A review of case reports-Reference-Cited by-同舟云学术

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports

Published:2020-03 Issue:3 Volume:11 Page:498-504
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Si Xiaoyan¹^ORCID,Song Peng¹^ORCID,Ni Jun¹^ORCID,Di Mingyi¹^ORCID,He Chunxia²,Zhang Li³,Liu Xiaowei⁴,Li Yue⁵,Wang Hanping¹^ORCID,Guo Xiaoxiao⁶^ORCID,Zhou Jiaxin⁷^ORCID,Duan Lian⁸,Yang Xu⁹,Wang Mengzhao¹,Zhang Li¹

Affiliation:

1. Department of Pulmonary and Critical Care MedicinePeking Union Medical College Hospital Beijing China

2. Department of DermatologyPeking Union Medical College Hospital Beijing China

3. Department of Clinical LaboratoryPeking Union Medical College Hospital Beijing China

4. Department of OphthalmologyPeking Union Medical College Hospital Beijing China

5. Department of GastroenterologyPeking Union Medical College Hospital Beijing China

6. Department of CardiologyPeking Union Medical College Hospital Beijing China

7. Department of RheumatologyPeking Union Medical College Hospital Beijing China

8. Department of EndocrinologyPeking Union Medical College Hospital Beijing China

9. Department of Liver SurgeryPeking Union Medical College Hospital Beijing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13315

Reference57 articles.

1. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

3. A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors

4. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological landscape of solid cancer: Interplay between tumor and autoimmunity;International Review of Cell and Molecular Biology;2024

2. Perspectives of data science in preclinical safety assessment;Drug Discovery Today;2023-08

3. Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials;Frontiers in Oncology;2022-12-08

4. Myasthenia gravis, myositis and myocarditis: a fatal triad of immune-related adverse effect of immune checkpoint inhibitor treatment;BMJ Case Reports;2022-12

5. Development of Management Strategies for Immune Related Adverse Effects of Immunotherapies used in Oncological Treatment;Asia-Pacific Journal of Oncology Nursing;2021-12